Patent ID: 8512709
Filing Date: 2013-08-20
Classification: A61K,A61P,C07K

Abstract:
1. A peptide consisting of peptide (a) and peptide (b), wherein: peptide (a) is selected from the group consisting of a peptide of the amino acid residues No. 1 to No. 10 from the N-terminal of SEQ ID NO:1, a peptide of the amino acid residues No. 2 to No. 10 from the N-terminal of SEQ ID NO:1, a peptide of the amino acid residues No. 3 to No. 10 from the N-terminal of SEQ ID NO:1, a peptide of the amino acid residues No. 1 to No. 9 from the N-terminal of SEQ ID NO:1, a peptide of the amino acid residues No. 2 to No. 9 from the N-terminal of SEQ ID NO:1, and a peptide of the amino acid residues No. 1 to No. 18 from the N-terminal of SEQ ID NO:1, and peptide (b) is selected from the group consisting of a peptide of the amino acid residues No. 28 to No. 36 from the N-terminal of SEQ ID NO:1, a peptide of the amino acid residues No. 28 to No. 37 from the N-terminal of SEQ ID NO:1, a peptide of the amino acid residues No. 28 to No. 38 from the N-terminal of SEQ ID NO:1, a peptide of the amino acid residues No. 28 to No. 39 from the N-terminal of SEQ ID NO:1, a peptide of the amino acid residues No. 28 to No. 40 from the N-terminal of SEQ ID NO:1, a peptide of the amino acid residues No. 28 to No. 41 from the N-terminal of SEQ ID NO:1, and a peptide of the amino acid residues No. 28 to No. 42 from the N-terminal of SEQ ID NO:1, wherein the C-terminal of peptide (a) is bound to the N-terminal of peptide (b), and wherein cysteine or a cysteine analog is bound to the C-terminal of a resulting combination of peptide (a) and peptide (b).